Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech
- Written by PR Newswire Asia - News Pronto RSS
- Race Oncology's drug Zantrene shown to protect human heart muscle cells from anthracycline-induced chemotherapy death. Anthracycline's are the most used and effective anti-cancer drugs, yet they can cause serious heart damage.
- The preclinical research also demonstrated Zantrene's ability to synergise with existing anthracyclines to better kill...
Read more: Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech